Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
about
Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trialStatins for primary prevention of venous thromboembolismHormone therapy for preventing cardiovascular disease in post-menopausal womenPhytoestrogens for menopausal vasomotor symptomsLong term hormone therapy for perimenopausal and postmenopausal womenStatins for primary prevention of venous thromboembolismLong term hormone therapy for perimenopausal and postmenopausal womenStatins for prevention of venous thromboembolismPhytoestrogens for vasomotor menopausal symptomsLong term hormone therapy for perimenopausal and postmenopausal womenNon-hormonal therapy for hot flushes in postmenopausal womenPrevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesBridging case-control studies and randomized trialsThe role of dyslipidemia and statins in venous thromboembolismGenetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in womenScreening, diagnosis and treatment of osteoporosis: a brief reviewThe epidemiology of venous thromboembolismPharmacological prevention of venous thromboembolism in medical patients at riskStatins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control studyRaloxifene and breast cancerEffect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trialsConcomitant use of prescription medications and dietary supplements in menopausal women: an approach to provider preparedness.Long-term hormone therapy for perimenopausal and postmenopausal women.Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility.Statins, hormones, and women: benefits and drawbacks for atherosclerosis and osteoporosis.Platelet adhesion onto immobilized fibrinogen under arterial and venous in-vitro flow conditions does not significantly differ between men and women.Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial.Thrombosis and antithrombotic therapy in womenMenopause and hormone replacement: Part 1. Evaluation and treatment.Making decisions about hormone replacement therapyA randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism.Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology.The epidemiology of venous thromboembolism in the community.Factor V Leiden thrombophilia.Hormones after menopause?Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study.2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.From adjuvant therapy to breast cancer prevention: BCPT and STAR.Assessing the role of oestrogen in the prevention of cardiovascular disease.
P2860
Q21256716-5682363C-883C-4D59-B62F-4501D1B3715CQ24187238-7EA2801D-240C-4430-A4F4-BCA59B583D1CQ24187326-C845D679-42D4-4E4C-B2CF-FBF208D49BBEQ24201856-7963BA75-6CF5-4AFD-B1ED-BA9AFE249593Q24201974-2030BBC0-7D77-4506-B09A-C0EEB5D491D5Q24204040-D63BB543-8639-4B9B-9797-263B194249E5Q24241279-3050D3F2-16AA-4B94-B7BD-39C90A4B3075Q24241510-9C7BE0CB-7EFC-4549-A34E-0AAC450C981FQ24243494-8963189E-4E16-402D-BCD9-D5C665435835Q24246577-20329F47-607E-43D1-9B2B-74A705438705Q24246936-3B007771-B642-4861-8141-2988EE26E0F2Q24633010-5074499E-E0B7-449D-B12A-E4259234EB28Q24793143-E91913C6-5926-4317-A970-692EE695FC7DQ24793360-C8293AA3-BB40-420D-9B99-8130334D7745Q24804326-D02024F6-D299-46C5-906C-3FB066E2F12EQ26996726-B6ACC8DE-B06D-4EDF-B381-F9BCD3F543ECQ28067893-F0C7152C-F6AA-438D-8B21-BCCD3136013BQ28193019-A43E72DF-A497-4973-A0BD-B9CF20909979Q28211027-D53BA4F0-7514-43A0-9702-E5A2DAB17362Q28361457-37336027-84CC-47BE-BD57-F4FDA2BE5DA2Q28483807-F6E4B112-75E0-4DA1-82F8-8B82DD7656ECQ30226808-D2483C4B-B6C8-405A-94E1-F8EFE2EF254AQ30238978-7FE598B7-E2F2-4850-9C26-DA3F000E077DQ30243926-7D1D05A9-493F-4F44-8A88-E62F14977579Q31729174-E6025FCA-7BBC-4831-9C31-AA68D029708AQ33282914-4CC3F35B-2D90-4D22-BCD8-3C11CBBD65DAQ33431611-D061AF6A-3B93-4ABB-93F0-FF562FFD83A4Q33569283-E6D72D20-CCF6-4C4D-BBDC-A7CCD3816BB8Q33729008-13035588-A84D-4078-BC84-415882A4D67EQ33813785-23E0BCB6-FC87-462E-AF2D-BAEDA0294A2AQ33820367-CBDBC68F-5B0E-455F-97BF-DA9C81538A61Q33826794-95E843F9-7EC2-448E-9545-F13ECDB697CEQ33828936-6836FF8A-6AE4-4D7B-8913-37ED2F914ADEQ33865646-2188175C-A171-48D2-BE07-B54F00EE6ABDQ34152374-5CCABA0A-6716-403F-9711-C04216538173Q34267973-1B2C48A9-F7BE-4C98-BFDD-78522758C3EBQ34288033-D22AC965-2CDF-4549-B987-E808F8383531Q34300668-430DF72A-BECE-49B7-A339-5AFB99B60767Q34317586-AAD09BDD-8417-433E-92A8-16C4CF0064F5Q34329552-47681F0A-7C3A-4164-8774-ED4343E476D6
P2860
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Postmenopausal hormone therapy ...... n/progestin Replacement Study.
@en
type
label
Postmenopausal hormone therapy ...... n/progestin Replacement Study.
@en
prefLabel
Postmenopausal hormone therapy ...... n/progestin Replacement Study.
@en
P2093
P1476
Postmenopausal hormone therapy ...... n/progestin Replacement Study.
@en
P2093
Herrington D
Hunninghake D
Vittinghoff E
P304
P356
10.7326/0003-4819-132-9-200005020-00002
P407
P577
2000-05-01T00:00:00Z